West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 844,900 | 805,000 | 804,600 | 766,500 | 698,000 |
| Cost of Goods | 548,500 | 501,100 | 510,300 | 492,600 | 466,100 |
| Gross Profit | 296,400 | 303,900 | 294,300 | 273,900 | 231,900 |
| Operating Expenses | 119,800 | 147,400 | 127,000 | 120,800 | 125,000 |
| Operating Income | 177,100 | 156,600 | 167,600 | 153,700 | 107,000 |
| Interest Expense | 1,900 | -200 | 200 | 100 | 400 |
| Other Income | 8,300 | 8,600 | 6,600 | 8,400 | 7,300 |
| Pre-tax Income | 183,500 | 165,400 | 174,000 | 162,000 | 113,900 |
| Income Tax | 44,700 | 33,300 | 34,000 | 30,200 | 24,100 |
| Net Income Continuous | 138,800 | 132,100 | 140,000 | 131,800 | 89,800 |
| Net Income | $138,800 | $132,100 | $140,000 | $131,800 | $89,800 |
| EPS Basic Total Ops | 1.93 | 1.83 | 1.94 | 1.82 | 1.24 |
| EPS Basic Continuous Ops | 1.93 | 1.83 | 1.94 | 1.83 | 1.24 |
| EPS Diluted Total Ops | 1.92 | 1.82 | 1.92 | 1.82 | 1.23 |
| EPS Diluted Continuous Ops | 1.92 | 1.81 | 1.93 | 1.82 | 1.23 |
| EPS Diluted Before Non-Recurring Items | N/A | 2.04 | 1.96 | 1.84 | 1.45 |
| EBITDA(a) | $222,300 | $203,600 | $210,600 | $195,100 | $147,000 |